Silvercrest Asset Management Group LLC Regeneron Pharmaceuticals, Inc. Transaction History

Silvercrest Asset Management Group LLC

  • $14.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$446.73 - $548.2 $482,021 - $591,507
-1,079 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$478.3 - $607.98 $11,957 - $15,199
25 Added 2.37%
1,079 $521,000
Q3 2020

Nov 16, 2020
BUY
$544.75 - $658.21 $2,179 - $2,632
4 Added 0.38%
1,054 $590,000
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $352,989 - $519,151
1,050 New
1,050 $513,000

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Silvercrest Asset Management Group LLC Portfolio

Follow Silvercrest Asset Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email